A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Clinical trial NCT06869551 · RECRUITING
Trial details
- NCT number
- NCT06869551
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-13
- Primary completion
- 2030-03-06
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.